These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 32725606
1. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy. Chikagawa Y, Hikishima K, Mizumaki H, Sugimori C, Nakagishi Y, Yachie A, Nakao S. Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606 [Abstract] [Full Text] [Related]
2. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A. J Infect Dis; 2010 Jun 15; 201(12):1923-32. PubMed ID: 20443735 [Abstract] [Full Text] [Related]
4. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis]. Fukuda M, Nishimura R, Araki R, Kuroda R, Mase S, Nakagawa Y, Tone Y, Maeba H, Wada T, Kasahara Y, Yachie A. Rinsho Ketsueki; 2012 Mar 15; 53(3):337-41. PubMed ID: 22499051 [Abstract] [Full Text] [Related]
5. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection. Lee WI, Lin JJ, Hsieh MY, Lin SJ, Jaing TH, Chen SH, Hung IJ, Yang CP, Chen CJ, Huang YC, Li SP, Huang JL. PLoS One; 2013 Mar 15; 8(10):e76711. PubMed ID: 24204658 [Abstract] [Full Text] [Related]
9. EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells. Yang C, Zhu X, Zhang T, Ye Q. Pediatr Res; 2017 Dec 15; 82(6):952-957. PubMed ID: 28738028 [Abstract] [Full Text] [Related]
10. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis. Ito Y, Kawamura Y, Iwata S, Kawada J, Yoshikawa T, Kimura H. Pediatr Blood Cancer; 2013 Feb 15; 60(2):326-8. PubMed ID: 22961815 [Abstract] [Full Text] [Related]
11. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH. Shamriz O, Kumar D, Shim J, Briones M, Quarmyne MO, Chonat S, Lucas L, Edington H, White MH, Mahajan A, Park S, Chandrakasan S. J Clin Immunol; 2021 Oct 15; 41(7):1582-1596. PubMed ID: 34173902 [Abstract] [Full Text] [Related]
12. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations. Wada T, Sakakibara Y, Nishimura R, Toma T, Ueno Y, Horita S, Tanaka T, Nishi M, Kato K, Yasumi T, Ohara O, Yachie A. Hum Immunol; 2013 Dec 15; 74(12):1579-85. PubMed ID: 24051121 [Abstract] [Full Text] [Related]
17. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol]. Xiao L, Xian Y, Dai BT, Su YC, Xiao JW, Zheng QC, Zhao XD, Yu J. Zhonghua Xue Ye Xue Za Zhi; 2011 Oct 15; 32(10):668-72. PubMed ID: 22339824 [Abstract] [Full Text] [Related]